Market Tracker

10/20 4:00am ET

Hyperion Therapeutics Inc (NASDAQ:HPTX)

22.76
Data as of Oct 17
 +0.59 / +2.66%
Today’s Change
18.97
Today|||52-Week Range
32.98
+12.56%
Year-to-Date

Today’s Trading

Previous close22.17
Today’s open22.62
Day’s range-- - --
Volume248,785
Average volume (3 months)139,309
Market cap$468.8M
Dividend yield--
Data as of 10/17/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-32.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio25.6
Price/Sales9.30
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc-1.69-7.01%
ONVOOrganovo Holdings In...0.000.00%
SZYMSolazyme Inc-0.48-7.13%
OSIROsiris Therapeutics ...-0.49-3.71%
Data as of 10/17/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$42.2M
Annual profit (last year)$16.6M
Net profit margin39.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts